Optum Ventures
Status
ACTIVE
Global HQ
Boston, United States
Countries of investment
- USA
- United Kingdom
Investment stages
- Seed
Industries
- Health Tech
- AI
- Fintech
- IT
About
Optum Ventures is a leading venture capital firm dedicated to transforming the health care landscape by collaborating with visionary entrepreneurs. With a focus on early-stage companies, Optum Ventures invests in innovative, data-driven technologies and services that challenge conventional practices. Their strategic partnerships aim to accelerate the development of groundbreaking solutions that enhance patient outcomes and streamline health care delivery, ultimately fostering a more efficient and accessible health care system. By leveraging their industry expertise and resources, Optum Ventures is committed to driving meaningful change in the health care sector.
Optum Ventures is a leading venture capital firm dedicated to transforming the health care landscape by collaborating with visionary entrepreneurs. With a focus on early-stage companies, Optum Ventures invests in innovative, data-driven technologies and services that challenge conventional practices. Their strategic partnerships aim to accelerate the development of groundbreaking solutions that enhance patient outcomes and streamline health care delivery, ultimately fostering a more efficient and accessible health care system. By leveraging their industry expertise and resources, Optum Ventures is committed to driving meaningful change in the health care sector.
Investment Thesis
Optum Ventures invests in transformational people and ideas to make health care better. They focus on partnering with extraordinary entrepreneurs to fundamentally change health care.
Manager's Experience
Backed by a team with extensive experience in healthcare innovation, the fund manager has actively engaged in various investment stages, primarily targeting early to growth-stage companies. They have built a diverse portfolio of over 30 investments across North America and Europe, focusing on sectors such as digital health, pharmaceuticals, and medical devices. Notable exits include several high-impact mergers and acquisitions that have significantly advanced healthcare delivery. With a strategic, operator-first approach, the firm emphasizes partnerships and operational support to drive value creation.
Team
Stephen Renfro
Dean Mccausland
Ben Freeberg
Anna Walsh
Tom Egan
Sheryl Tapia
Breitenstein